Clinical Trials Directory

Trials / Completed

CompletedNCT01913548

Multi-Center Study of Iron Overload: Survey Study (MCSIO)

Modulation of Iron Deposition in Sickle Cell Disease and Other Hemoglobinopathies SURVEY STUDY

Status
Completed
Phase
Study type
Observational
Enrollment
423 (actual)
Sponsor
UCSF Benioff Children's Hospital Oakland · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to demonstrate that a sufficient number of iron-overloaded thalassemia (THAL), Sickle Cell Disease (SCD)and Diamond Blackfan Anemia (DBA) populations with similar duration of chronic transfusion, and age at start of transfusions would be available for a confirmatory study. The study will examine the hypothesis that a chronic inflammatory state in SCD leads to hepcidin- and cytokine-mediated iron withholding within the RES (reticuloendothelial system), lower plasma NTBI (non-transferrin bound iron) levels, less distribution of iron to the heart in SCD.

Detailed description

A detailed iron burden, transfusion and chelation history will be obtained from chart review or from participant recall. Iron burden data will include: 1) documentation of liver iron, and 2) average annual ferritin values. Transfusion data will include: (1) age at onset of regular transfusions, (2) years of chronic transfusion therapy, and (3) pre-transfusion Hb calculated as average of all assessments for each year.

Conditions

Timeline

Start date
2010-03-31
Primary completion
2013-08-31
Completion
2013-10-31
First posted
2013-08-01
Last updated
2020-09-23

Locations

8 sites across 3 countries: United States, Germany, United Kingdom

Source: ClinicalTrials.gov record NCT01913548. Inclusion in this directory is not an endorsement.